The lead clinician should: discuss the management of any of the issues identified in section 5.5.1) explain the treatment summary and follow-up care plan provide information about the signs and symptoms of recurrent disease provide information about secondary prevention and healthy living provide clear information about the role and benefits of palliative care.

The lead clinician should ensure regular, timely, two-way communication with the woman’s general practitioner regarding: the follow-up care plan potential late effects supportive and palliative care requirements the woman’s progress recommendations from the multidisciplinary team any shared care arrangements a process for rapid re-entry to medical services for women with suspected recurrence.

After initial treatment, the woman, the woman’s nominated carer (as appropriate) and general practitioner should receive a treatment summary outlining: the diagnostic tests performed and results tumour characteristics the type and date of treatment(s) interventions and treatment plans from other health professionals supportive care services provided contact information for key care providers.

The lead clinician should: discuss with the general practitioner their role in symptom management, psychosocial care and referral to local services ensure regular and timely two-way communication regarding: the treatment plan, including intent and potential side effects supportive and palliative care requirements the woman’s prognosis and their understanding of this enrolment in research and/or clinical…

Screening, assessment and referral to appropriate health professionals is required to meet the identified needs of the woman, her carer and family. In addition to the common issues identified in the Appendix, specific issues that may arise at this time include: emotional and psychological distress from anticipatory grief, fear of death/dying, anxiety/ depression, interpersonal problems…

The lead clinician should: discuss the treatment plan with the woman and carer, including the intent of treatment and expected outcomes, and provide a written plan provide the woman and carer with information on the possible side effects of treatment, self-management strategies and emergency contacts initiate a discussion regarding advance care planning with the woman…

The lead clinician should: be open to and encourage discussion about the expected disease course, with due consideration to personal and cultural beliefs and expectations discuss palliative care options including inpatient and community-based services as well as dying at home and subsequent arrangements provide the woman and her carer with the contact details of a…

The lead clinician should discuss end-of-life care planning and transition planning to ensure the woman’s needs and goals are addressed in the appropriate environment. The woman’s general practitioner should be kept fully informed and involved in major developments in the woman’s illness trajectory.

Screening, assessment and referral to appropriate health professionals is required to meet the identified needs of an individual, their carer and family. In addition to the common issues outlined in the Appendix, specific issues that may arise include: emotional and psychological distress resulting from fear of death/dying, existential concerns, anticipatory grief, communicating wishes to loved…

Rehabilitation may be required at any point of the care pathway from preparing for treatment through to disease-free survival and palliative care. Issues that may need to be addressed include managing cancer-related fatigue, cognitive changes, improving physical endurance, achieving independence in daily tasks, returning to work and ongoing adjustment to disease and its sequelae.